Annual FCF
-$137.31 M
+$18.61 M+11.94%
31 December 2023
Summary:
Kymera Therapeutics annual free cash flow is currently -$137.31 million, with the most recent change of +$18.61 million (+11.94%) on 31 December 2023. During the last 3 years, it has fallen by -$6.76 million (-5.18%). KYMR annual FCF is now -273.73% below its all-time high of $79.03 million, reached on 31 December 2020.KYMR Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
-$50.00 M
-$2.38 M-4.99%
30 September 2024
Summary:
Kymera Therapeutics quarterly free cash flow is currently -$50.00 million, with the most recent change of -$2.38 million (-4.99%) on 30 September 2024. Over the past year, it has dropped by -$46.42 million (-1296.68%). KYMR quarterly FCF is now -138.68% below its all-time high of $129.26 million, reached on 30 September 2020.KYMR Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
-$148.20 M
-$10.28 M-7.45%
30 September 2024
Summary:
Kymera Therapeutics TTM free cash flow is currently -$148.20 million, with the most recent change of -$10.28 million (-7.45%) on 30 September 2024. Over the past year, it has dropped by -$10.89 million (-7.93%). KYMR TTM FCF is now -247.40% below its all-time high of $100.54 million, reached on 30 September 2020.KYMR TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
KYMR Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | -1296.7% | -7.9% |
| 3 y3 years | -5.2% | -28.7% | -13.5% |
| 5 y5 years | -890.3% | - | - |
KYMR Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -5.2% | +11.9% | -1296.7% | at low | -13.5% | +14.7% |
| 5 y | 5 years | -273.7% | +11.9% | -138.7% | at low | -247.4% | +14.7% |
| alltime | all time | -273.7% | +11.9% | -138.7% | at low | -247.4% | +14.7% |
Kymera Therapeutics Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$50.00 M(+5.0%) | -$148.20 M(+7.5%) |
| June 2024 | - | -$47.63 M(+1.3%) | -$137.92 M(+1.2%) |
| Mar 2024 | - | -$46.99 M(+1212.7%) | -$136.32 M(-0.7%) |
| Dec 2023 | -$137.31 M(-11.9%) | -$3.58 M(-91.0%) | -$137.31 M(-20.9%) |
| Sept 2023 | - | -$39.73 M(-13.7%) | -$173.63 M(+2.5%) |
| June 2023 | - | -$46.02 M(-4.1%) | -$169.43 M(+3.9%) |
| Mar 2023 | - | -$47.98 M(+20.2%) | -$163.12 M(+4.6%) |
| Dec 2022 | -$155.92 M | -$39.91 M(+12.4%) | -$155.92 M(+0.7%) |
| Sept 2022 | - | -$35.52 M(-10.6%) | -$154.87 M(-1.3%) |
| June 2022 | - | -$39.72 M(-2.6%) | -$156.92 M(+5.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$40.78 M(+5.0%) | -$148.33 M(+13.6%) |
| Dec 2021 | -$130.54 M(-265.2%) | -$38.85 M(+3.4%) | -$130.54 M(+15.3%) |
| Sept 2021 | - | -$37.57 M(+20.6%) | -$113.19 M(-311.1%) |
| June 2021 | - | -$31.14 M(+35.5%) | $53.63 M(-22.8%) |
| Mar 2021 | - | -$22.99 M(+6.9%) | $69.50 M(-12.1%) |
| Dec 2020 | $79.03 M(+354.9%) | -$21.50 M(-116.6%) | $79.03 M(-21.4%) |
| Sept 2020 | - | $129.26 M(-946.6%) | $100.54 M(-450.1%) |
| June 2020 | - | -$15.27 M(+13.5%) | -$28.72 M(+113.5%) |
| Mar 2020 | - | -$13.45 M | -$13.45 M |
| Dec 2019 | $17.37 M(-190.4%) | - | - |
| Dec 2018 | -$19.22 M | - | - |
FAQ
- What is Kymera Therapeutics annual free cash flow?
- What is the all time high annual FCF for Kymera Therapeutics?
- What is Kymera Therapeutics quarterly free cash flow?
- What is the all time high quarterly FCF for Kymera Therapeutics?
- What is Kymera Therapeutics quarterly FCF year-on-year change?
- What is Kymera Therapeutics TTM free cash flow?
- What is the all time high TTM FCF for Kymera Therapeutics?
- What is Kymera Therapeutics TTM FCF year-on-year change?
What is Kymera Therapeutics annual free cash flow?
The current annual FCF of KYMR is -$137.31 M
What is the all time high annual FCF for Kymera Therapeutics?
Kymera Therapeutics all-time high annual free cash flow is $79.03 M
What is Kymera Therapeutics quarterly free cash flow?
The current quarterly FCF of KYMR is -$50.00 M
What is the all time high quarterly FCF for Kymera Therapeutics?
Kymera Therapeutics all-time high quarterly free cash flow is $129.26 M
What is Kymera Therapeutics quarterly FCF year-on-year change?
Over the past year, KYMR quarterly free cash flow has changed by -$46.42 M (-1296.68%)
What is Kymera Therapeutics TTM free cash flow?
The current TTM FCF of KYMR is -$148.20 M
What is the all time high TTM FCF for Kymera Therapeutics?
Kymera Therapeutics all-time high TTM free cash flow is $100.54 M
What is Kymera Therapeutics TTM FCF year-on-year change?
Over the past year, KYMR TTM free cash flow has changed by -$10.89 M (-7.93%)